Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0001470831-26-000819

Options or other derivatives

  • Chief Financial Officer acquired 285,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Larson Jennifer · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-12 Grant or award : show line 1 in the form Stock Option (Right to Buy) +285,000 285,000 D
Loading xslF345X06/wk-form4_1786740871.xml…